Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling

Dose recommendations for lamivudine or emtricitabine in children with HIV and chronic kidney disease (CKD) are absent or not supported by clinical data. Physiologically based pharmacokinetic (PBPK) models have the potential to facilitate dose selection for these drugs in this population. Existing la...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Tom G., de Hoop-Sommen, Marika A., Nieuwenstein, Thomas, van der Heijden, Joyce E. M., de Wildt, Saskia N., Burger, David M., Colbers, Angela, Freriksen, Jolien J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221211/
https://www.ncbi.nlm.nih.gov/pubmed/37242665
http://dx.doi.org/10.3390/pharmaceutics15051424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221211/
https://www.ncbi.nlm.nih.gov/pubmed/37242665
http://dx.doi.org/10.3390/pharmaceutics15051424

Ejemplares similares